Table 1.
Summary table
| Code number | Commodity | Existing EU MRL (mg/kg) | Existing CXL (mg/kg) | Outcome of the review | |
|---|---|---|---|---|---|
| MRL (mg/kg) | Comment | ||||
|
Enforcement residue definition (existing): imazalil Enforcement residue definition 1 (proposed): imazalil (any ratio of constituent isomers) | |||||
| 110010 | Grapefruits | 5 | 5 | 4 | Further consideration neededa |
| 110020 | Oranges | 5 | 5 | 4 | Further consideration neededa |
| 110030 | Lemons | 5 | 5 | 6 | Further consideration neededb |
| 110040 | Limes | 5 | 5 | 6 | Further consideration neededb |
| 110050 | Mandarins | 5 | 5 | 6 | Further consideration neededb |
| 130010 | Apples | 2 | 5 | – | Further consideration neededc |
| 130020 | Pears | 2 | 5 | – | Further consideration neededc |
| 130030 | Quinces | 2 | 5 | – | Further consideration neededd |
| 130040 | Medlar | 5 | 5 | – | Further consideration neededd |
| 130050 | Loquat | 5 | 5 | – | Further consideration neededd |
| 152000 | Strawberries | 0.05* | 2 | 2 | Further consideration needede |
| 153010 | Blackberries | 0.05* | 2 | 2 | Further consideration needede |
| 153030 | Raspberries | 0.05* | 2 | 2 | Further consideration needede |
| 161060 | Persimmon | 0.05* | 2 | – | Further consideration neededf |
| 163020 | Bananas | 2 | 2 | 5 | Further consideration neededb |
| 211000 | Potatoes | 3 | 5 | 0.01* | Recommendedg |
| 231010 | Tomatoes | 0.5 | – | 0.3 | Recommendedh |
| 231020 | Sweet peppers/bell peppers | 0.05* | – | 0.05 | Further consideration neededi |
| 232010 | Cucumbers | 0.2 | 0.5 | 0.5 | Recommendedj |
| 232020 | Gherkins | 0.2 | 0.5 | 0.5 | Recommendedj |
| 232030 | Courgettes | 0.2 | – | 0.1 | Further consideration neededk |
| 233010 | Melons | 2 | 2 | 2 | Further consideration neededl |
| 500010 | Barley grains | 0.05* | – | 0.01* | Recommendedh |
| 500050 | Oat grains | 0.05* | – | 0.01* | Recommendedh |
| 500070 | Rye grains | 0.05* | – | 0.01* | Recommendedh |
| 500090 | Wheat grains | 0.05* | 0.01* | 0.01* | Recommendedm |
| – | Other commodities of plant origin | See Reg. 750/2010 | – | – | Further consideration neededn |
|
Enforcement residue definition (existing): imazalil Enforcement residue definition 2 (proposed): sum of imazalil and metabolite FK‐772 (any ratio of constituent isomers), expressed as imazalil | |||||
| 1011010 | Swine muscle | 0.05* | – | 0.02* | Further consideration neededk |
| 1011020 | Swine fat tissue | 0.05* | – | 0.02* | Further consideration neededk |
| 1011030 | Swine liver | 0.05* | – | 0.02* | Further consideration neededk |
| 1011040 | Swine kidney | 0.05* | – | 0.02* | Further consideration neededk |
| 1012010 | Bovine muscle | 0.05* | – | 0.02* | Further consideration neededk |
| 1012020 | Bovine fat tissue | 0.05* | – | 0.02* | Further consideration neededk |
| 1012030 | Bovine liver | 0.05* | – | 0.03 | Further consideration neededk |
| 1012040 | Bovine kidney | 0.05* | – | 0.02* | Further consideration neededk |
| 1015010 | Equine muscle | 0.05* | – | 0.02* | Further consideration neededk |
| 1015020 | Equine fat tissue | 0.05* | – | 0.02* | Further consideration neededk |
| 1015030 | Equine liver | 0.05* | – | 0.03 | Further consideration neededk |
| 1015040 | Equine kidney | 0.05* | – | 0.02* | Further consideration neededk |
| 1020010 | Cattle milk | 0.05* | – | 0.02* | Further consideration neededk |
| 1020040 | Horse milk | 0.05* | – | 0.02* | Further consideration neededk |
| – | Other commodities of animal origin | See Reg. 750/2010 | – | – | Further consideration neededn |
MRL: maximum residue level; CXL: codex maximum residue limit.
* Indicates that the MRL is set at the limit of quantification.
Tentative MRL is derived from a GAP evaluated at EU level, which is not fully supported by data but for which no risk to consumers was identified; CXL is higher but it is also not sufficiently supported by data and a risk to consumers cannot be excluded (combination E‐IV in Appendix E).
Tentative MRL is derived from a GAP evaluated at EU level, which is not fully supported by data but for which no risk to consumers was identified; existing CXL is covered by the tentative MRL (combination E‐III in Appendix E).
GAP evaluated at EU level is fully supported by data but a risk to consumers cannot be excluded; CXL is not sufficiently supported by data and a risk to consumers can also not be excluded. Either a specific LOQ or the default MRL of 0.01 mg/kg may be considered (combination F‐IV in Appendix E).
There are no relevant authorisations or import tolerances reported at EU level; CXL is not sufficiently supported by data and a risk to consumers cannot be excluded. Either a specific LOQ or the default MRL of 0.01 mg/kg may be considered (combination A‐IV in Appendix E).
MRL is derived from the existing CXL, which is not sufficiently supported by data but for which no risk to consumers is identified; there are no relevant authorisations or import tolerances reported at EU level (combination A‐V in Appendix E).
There are no relevant authorisations or import tolerances reported at EU level; CXL is supported by data but a risk to consumers cannot be excluded. Either a specific LOQ or the default MRL of 0.01 mg/kg may be considered (combination A‐VI in Appendix E).
MRL is derived from a GAP evaluated at EU level, which is fully supported by data and for which no risk to consumers is identified; CXL is higher but it is not sufficiently supported by data and a risk to consumers cannot be excluded (combination G‐IV in Appendix E).
MRL is derived from a GAP evaluated at EU level, which is fully supported by data and for which no risk to consumers is identified; no CXL is available (combination G‐I in Appendix E).
GAP evaluated at EU level is not supported by data but no risk to consumers was identified for the existing EU MRL; no CXL is available (combination C‐I in Appendix E).
MRL is derived from the existing CXL, which is supported by data and for which no risk to consumers is identified; GAP evaluated at EU level, which is not fully supported by data, leads to a lower tentative MRL (combination E‐VII in Appendix E).
Tentative MRL is derived from a GAP evaluated at EU level, which is not fully supported by data but for which no risk to consumers was identified; no CXL is available (combination E‐I in Appendix E).
GAP evaluated at EU level is not supported by data but no risk to consumers was identified for the existing EU MRL; existing CXL is covered by the existing EU MRL (combination C‐III in Appendix E).
MRL is derived from a GAP evaluated at EU level, which is fully supported by data and for which no risk to consumers is identified; existing CXL is covered by the recommended MRL (combination G‐III in Appendix E).
There are no relevant authorisations or import tolerances reported at EU level; no CXL is available. Either a specific LOQ or the default MRL of 0.01 mg/kg may be considered (combination A‐I in Appendix E).